Skip to main content

8-K

EDGEWELL PERSONAL CARE Co (EPC)

8-K 2020-02-10 For: 2020-02-06
View Original
Added on April 08, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________

FORM 8-K

______________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (date of earliest event reported): February 6, 2020

epc-20200206_g1.jpg

EDGEWELL PERSONAL CARE COMPANY

(Exact name of registrant as specified in its charter)

Missouri 1-15401 43-1863181
(State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.)

6 Research Drive, Shelton, Connecticut 06484

(Address of principal executive offices)

203-944-5500

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share EPC New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07 Submission of Matters to a Vote of Security Holders.

The Company held its annual meeting of shareholders (the “Annual Meeting”) on Thursday, February 6, 2020. Of the 54,300,084 shares outstanding and entitled to vote at the Annual Meeting, 50,165,818 shares were represented in person or by proxy, constituting a quorum.

The final results for each of the matters submitted to a vote of shareholders at the Annual Meeting are as follows:

Proposal 1: Management's nominees for director were elected to serve until the Annual Meeting of Shareholders to be held in 2021 or until their respective successors are elected and qualified, by the votes set forth in the table below:

Nominee For Against Abstain Broker Non-Votes
Robert W. Black 45,673,858 792,979 60,967 3,638,014
George R. Corbin 45,979,703 379,006 169,095 3,638,014
Daniel J. Heinrich 45,491,738 959,820 76,246 3,638,014
Carla C. Hendra 45,382,901 1,063,435 81,468 3,638,014
R. David Hoover 45,480,276 970,744 76,784 3,638,014
John C. Hunter, III 45,662,196 790,165 75,443 3,638,014
James C. Johnson 44,471,845 1,980,960 74,999 3,638,014
Rod R. Little 46,248,696 201,921 77,187 3,638,014
Joseph D. O’Leary 46,092,381 358,198 77,225 3,638,014
Rakesh Sachdev 45,636,253 812,390 79,161 3,638,014
Gary K. Waring 45,799,439 653,110 75,255 3,638,014

Proposal 2: The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal 2020 was ratified by the shareholders by the votes set forth in the table below:

For Against Abstain
48,788,854 1,313,573 63,391

Proposal 3: The Company's executive compensation, as described in the Company's Proxy Statement, was approved by the non-binding advisory votes of the shareholders as set forth in the table below:

For Against Abstain Broker Non-Votes
35,576,421 10,844,515 106,868 3,638,014

Proposal 4: The Company's Amended and Restated 2018 Stock Incentive Plan, as described in the Company's Proxy Statement, was approved by the votes of the shareholders as set forth in the table below:

For Against Abstain Broker Non-Votes
42,324,334 1,574,038 2,629,432 3,638,014

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description
101 Cover page information from Edgewell Personal Care Company's Current Report on Form 8-K filed on February 10, 2020, formatted in iXBRL (Inline Extensible Business Reporting Language).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

EDGEWELL PERSONAL CARE COMPANY

By:  /s/ Marisa B. Iasenza

Marisa B. Iasenza

Chief Legal Officer

Dated: February 10, 2020